J. Sun

发表

Suppression of hepatitis C virus replication by protein kinase C‐related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase

S. Kim, J. Kim, J. Sun, 2009, Journal of viral hepatitis.

Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study

S-H. Jung, S. Lee, J. Sun, 2022, ESMO open.

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.

M. Ahn, E. Choi, S-H. Jung, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of concurrent thoracic radiotherapy with either fi rst-or third-cycle chemotherapy for limited-disease small-cell lung cancer †

M. Ahn, E. Choi, S-H. Jung, 2013 .

LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

M. Shah, P. Sunpaweravong, P. Enzinger, 2020 .

Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer.

M. Shah, P. Enzinger, Y. Zhu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients.

M. Ahn, W. Park, V. Anagnostou, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.

Sin-Ho Jung, M. Ahn, Keunchil Park, 2016, European journal of cancer.

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

J. Ahn, M. Ahn, Keunchil Park, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer.

X. Song, J. Sun, P. Zhou, 2016, European review for medical and pharmacological sciences.

Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing.

M. Ahn, Jong-Mu Sun, J. Ahn, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer.

J. Y. Lee, D. Na, M. Ahn, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy.

M. Ahn, E. Cho, B. Cho, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing.

M. Ahn, J. Ahn, J. Ji, 2015 .

The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations

J. Ahn, M. Ahn, Keunchil Park, 2012, Human Genetics.

Dacomitinib in EGFR-mutant non-small-cell lung cancer with brain metastasis: a single-arm, phase II study.

J. Sun, H. Jung, J. Ahn, 2023, ESMO open.